Asian Growth Companies With Strong Insider Ownership
Amidst fluctuating global markets, Asian equities have shown resilience, with a focus on high-growth sectors despite economic uncertainties and geopolitical tensions. In this context, companies in Asia with strong insider ownership often attract attention as they may signal confidence from those closest to the business.
Top 10 Growth Companies With High Insider Ownership In Asia
| Name | Insider Ownership | Earnings Growth |
| Suzhou Dongshan Precision Manufacturing (SZSE:002384) | 33.5% | 75.2% |
| Shanghai Biren Technology (SEHK:6082) | 10.4% | 118.4% |
| Seojin SystemLtd (KOSDAQ:A178320) | 18% | 110.8% |
| SEERS (KOSDAQ:A458870) | 33.8% | 39.7% |
| Ningbo Sanxing Medical ElectricLtd (SHSE:601567) | 24.9% | 45.6% |
| Meitu (SEHK:1357) | 22.8% | 31.3% |
| HUMAN MADE (TSE:456A) | 23.9% | 29.2% |
| Great Microwave Technology (SHSE:688270) | 29.5% | 85.5% |
| Fulin Precision (SZSE:300432) | 11.2% | 60.7% |
| Biocytogen Pharmaceuticals (Beijing) (SEHK:2315) | 14.1% | 41% |
Below we spotlight a couple of our favorites from our exclusive screener.
PharmaResearch (KOSDAQ:A214450)
Simply Wall St Growth Rating: ★★★★★☆
Overview: PharmaResearch Co., Ltd., along with its subsidiaries, is a biopharmaceutical company operating mainly in South Korea, with a market capitalization of approximately ₩4.32 trillion.
Operations: The company generates revenue primarily from its pharmaceuticals segment, which amounts to approximately ₩565.48 billion.
Insider Ownership: 35%
Earnings Growth Forecast: 21.9% p.a.
PharmaResearch demonstrates potential as a growth company with high insider ownership in Asia. The company's earnings grew by 59.1% over the past year, and it is trading at 54.5% below estimated fair value, suggesting room for appreciation. Revenue is forecast to grow at 20.2% annually, outpacing the Korean market's 14.4%. Despite expectations of slower profit growth than the market average, analysts anticipate a stock price rise of 22.2%.
- Take a closer look at PharmaResearch's potential here in our earnings growth report.
- The analysis detailed in our PharmaResearch valuation report hints at an deflated share price compared to its estimated value.
Chinasoft International (SEHK:354)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Chinasoft International Limited, with a market cap of HK$9.53 billion, operates as a software and information technology services company across several countries including China, Malaysia, Japan, Saudi Arabia, Singapore, India, and Indonesia.
Operations: Chinasoft International Limited generates revenue through its software and IT services operations across regions including China, Malaysia, Japan, Saudi Arabia, Singapore, India, and Indonesia.
Insider Ownership: 10.6%
Earnings Growth Forecast: 33.1% p.a.
Chinasoft International is experiencing strong growth, with earnings forecasted to increase significantly at 33.1% annually, outpacing the Hong Kong market. Recent strategic alliances, such as the partnership with Moonshot AI, bolster its position in AI and enterprise services. The company's recent earnings report showed improved net income and sales figures. Insider activity has been positive, with more shares bought than sold recently, indicating confidence in its future prospects.
- Dive into the specifics of Chinasoft International here with our thorough growth forecast report.
- The analysis detailed in our Chinasoft International valuation report hints at an inflated share price compared to its estimated value.
SHIFT (TSE:3697)
Simply Wall St Growth Rating: ★★★★★☆
Overview: SHIFT Inc. offers software quality assurance and testing solutions in Japan, with a market cap of ¥248.09 billion.
Operations: The company's revenue is primarily derived from Software Testing Related Services, amounting to ¥96.96 billion, and Software Development Related Services, contributing ¥46.30 billion.
Insider Ownership: 32.9%
Earnings Growth Forecast: 40.6% p.a.
SHIFT is poised for robust growth, with earnings expected to rise significantly at 40.6% annually, surpassing the Japanese market. Despite a volatile share price and lower profit margins compared to last year, the company trades below its estimated fair value. Recent strategic moves include expanding AI services and acquiring Nisseicom, which contributed to an upward revision of sales forecasts. However, earnings guidance was lowered due to non-operating expenses impacting profits.
- Click here to discover the nuances of SHIFT with our detailed analytical future growth report.
- The valuation report we've compiled suggests that SHIFT's current price could be quite moderate.
Turning Ideas Into Actions
- Get an in-depth perspective on all 493 Fast Growing Asian Companies With High Insider Ownership by using our screener here.
- Searching for a Fresh Perspective? Outshine the giants: these 18 early-stage AI stocks could fund your retirement.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com